Seres Therapeutics Inc (MCRB)
0.9244
-0.03
(-3.50%)
USD |
NASDAQ |
May 16, 16:00
0.947
+0.02
(+2.44%)
Pre-Market: 08:01
Seres Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -64.45K% |
| September 30, 2023 | -15.44K% |
| June 30, 2023 | 36.81% |
| March 31, 2023 | |
| December 31, 2022 | -7.06K% |
| September 30, 2022 | -1.74K% |
| June 30, 2022 | -5.32K% |
| March 31, 2022 | -3.79K% |
| December 31, 2021 | -603.1% |
| September 30, 2021 | 53.83% |
| June 30, 2021 | -918.3% |
| March 31, 2021 | -620.2% |
| December 31, 2020 | -103.9% |
| September 30, 2020 | -2.14K% |
| June 30, 2020 | -342.7% |
| March 31, 2020 | -242.8% |
| Date | Value |
|---|---|
| December 31, 2019 | -246.4% |
| September 30, 2019 | -233.4% |
| June 30, 2019 | -85.86% |
| March 31, 2019 | -332.4% |
| December 31, 2018 | -200.3% |
| September 30, 2018 | -242.4% |
| June 30, 2018 | -602.5% |
| March 31, 2018 | -703.1% |
| December 31, 2017 | -947.4% |
| September 30, 2017 | -30.13% |
| June 30, 2017 | -929.6% |
| March 31, 2017 | -844.9% |
| December 31, 2016 | -832.5% |
| September 30, 2016 | -143.6% |
| June 30, 2016 | -929.2% |
| March 31, 2016 | -727.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-64.45K%
Minimum
Dec 2023
53.83%
Maximum
Sep 2021
-5.74K%
Average
-611.7%
Median
Profit Margin (Quarterly) Benchmarks
| Integra Lifesciences Holdings Corp | -0.89% |
| Nuwellis Inc | -233.2% |
| Axogen Inc | -16.04% |
| Axsome Therapeutics Inc | -91.14% |
| 908 Devices Inc | -109.3% |